II Workshop on Medicines Regulation in the Caribbean: “Strengthening of National Medicines Regulation Authorities”
Barbados, September 8-9, 2009
•To strengthen mechanisms of collaboration and harmonization of regulation of medicines in the Caribbean
Specific Objectives:-To establish priorities and to design strategies for strengthening and harmonizing the regulation of medicines in the Caribbean in the context of the essential public health functions,
-To share the outcomes of surveys related to pharmaceutical situation and the assessment of national regulatory authorities in the Caribbean;
-To design and discuss mechanisms of communication and collaboration among regulatory authorities.
-To identify the possible common legal framework, guidelines and technical documents for strengthening essential regulatory functions;
-To discuss possibilities to strengthening the Human Resource capacity for regulation of medicines.
14 Caribbean countries, Organization of Eastern Caribbean States Pharmaceutical Procurement Service (OECS/PPS) and experts from SECMED (Cuba), National Medicines, Food and Medical Technology Authority (ANMAT-Argentina), The National Health Surveillance Agency (ANVISA-Brasil) and The US Food and Drug Administration (FDA-United States).
- Regulatory Function of Drug Registration(Dr. Celeste Sánchez González)
- Strengthening the National Regulatory Authorities and the Essential Regulatory Functions (Dr. Adriana Mitsue Ivama)
- Pharmaceutical Situation (Dr. Adriana Mistue Ivama)
- The Regulatory dimension as an Essential Public Health Function (Dr. Gabriel Vivas)
- Current Status of Pan American Network for Drug Regulatory Harminization (PANDRH) (Dr. James Fitzgerald)
- Essential Regulatory Functions: Quality Assurance The CRDTL Experience (Dr. Lucette Cargill)
- Experiences on harmonization and mechanisms of sub-regional integration